| yeast |
cohort |
7 |
3 |
S. cerevisiae, YEAST |
| Yoruba |
cohort |
8 |
3 |
YRI, Yoruba, Yoruba population, Yoruba sample, Yoruban population |
| Young adult cohort |
cohort |
6 |
3 |
population-based sample of young adults, young adult cohort, young adults |
| young adults |
cohort |
70 |
40 |
1,399,489 young adults, 18–29 years of age, age 30–44, ages 12-31, early adulthood, participants, trauma-exposed young adults, young adult, young adult community sample, young adult group, young adult participants, young adult period, young adult population, young adult sample, young adulthood, young adults, young adults (age 18-28), young adults (ages 12 to 25), ≥ 19 years |
| Younger adults |
cohort |
4 |
3 |
young adults, younger, younger counterparts |
| younger cohort |
cohort |
15 |
6 |
MTFS, MTFS younger cohort, Phase 2, age 11 cohort, age: younger, younger cohort, younger participants, younger populations |
| younger participants |
cohort |
2 |
— |
younger participants |
| young women |
cohort |
6 |
4 |
women, young women |
| YRI |
cohort |
19 |
12 |
African (YRI), Africans, HapMap African, HapMap YRI, YRI, YRI analysis panels, Yoruba, Yoruba in Ibadan, Nigeria, Yoruba people of Ibadan, Nigeria, Yoruba, Nigeria |
| zaleplon |
drug |
2 |
1 |
|
| ZBTB16 |
gene |
3 |
2 |
Zinc finger and BTB domain containing 16 |
| ZDHHC5 |
gene |
2 |
2 |
ZDHHC5 protein, zinc finger DHHC-type palmitoyltransferase 5 |
| ZEB2 |
gene |
2 |
1 |
SIP1, Zfhx1b |
| zebrafish |
cohort |
6 |
2 |
Danio rerio |
| ZNF512 |
gene |
2 |
2 |
|
| zolpidem |
drug |
5 |
3 |
|
| zygosity |
phenotype |
7 |
2 |
zygosity |
| β-actin |
gene |
6 |
3 |
ACTB |
| β-catenin |
drug |
5 |
6 |
CTNNB1, Wnt signaling, β-catenin signaling |
| β-endorphin |
drug |
7 |
5 |
beta endorphin, beta-endorphin, endogenous ligand for μ-opioid receptor, β-endorphin |
